Publication | Closed Access

Long-term Inhaled Nitric Oxide Plus Phosphodiesterase 5 Inhibitors for Severe Pulmonary Hypertension

Molecular PharmacologyHypertensionPulmonary Arterial HypertensionPulmonary CirculationCardiovascular DiseaseSevere Pulmonary HypertensionMedicineAntihypertensive TherapyPulmonary PhysiologyPulmonary PharmacologyPulmonary HypertensionPulmonary MedicinePharmacotherapyPublic HealthPharmacologyPulmonary Vascular DiseaseAnesthesiology